All SARS-CoV-2 articles – Page 13
-
News“Honey, I shrunk the cookbook” – new approach to vaccine development
Bioinformaticians have presented a method for identifying epitopes that promise safe immunisation across the broadest possible population group.
-
NewsMedicinal plants offer hope for drug discovery and development against COVID-19
A new book offers insights into treating SARS-CoV-2 infections and respiratory problems, highlighting prospective drug discovery opportunities based on bioactive components from medicinal plants and herbal remedies.
-
NewsNew oral treatment reduces duration and symptoms of mild COVID-19
The treatment acts on the replication mechanism of SARS-CoV-2, the virus responsible for the disease, and reduces the severity and duration of some of the symptoms. In addition, it can be useful to treat the different mutations detected.
-
NewsCOVID-19 infection causes teen’s vocal cord paralysis in first-of-its-kind case
Physician-researchers have reported the first pediatric case of bilateral vocal cord paralysis after COVID-19 infection.
-
NewsB cell deficient patients gain protective T cell immunity after SARS-CoV-2 vaccination, infection
Researchers found that vaccinated B cell-deficient individuals had significantly reduced risk of moderate and severe disease in comparison to those who were not vaccinated, despite an absence of anti-spike antibody responses.
-
NewsCOVID-19 infection alters gene transcription of olfactory mucosal cells in Alzheimer’s disease
A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer’s disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 outcomes.
-
NewsOmicron induces cellular senescence in human lung, study finds
Researchers investigating the influence of defined altered spike formations have confirmed that the Omicron variant induces cellular senescence in human lungs of COVID-19 patients.
-
NewsResearchers pave way for next generation COVID-19 immunization strategies
A vaccine booster delivered directly to mucosal site of infection enhances protection against COVID-19 infection in non-human primates, a new study reveals.
-
NewsRisk of death reduces after COVID-19 vaccine but protection wanes after six months
The risk of death from COVID-19 decreases significantly after vaccination but this protection diminishes after six months, providing evidence for continued booster doses, a new study has found.
-
News‘Long flu’ has emerged as a consequence similar to long COVID
A new study shows patients hospitalized for flu or COVID-19 face an increased risk of long-term health problems and death.
-
NewsSilent carriers: long-standing SARS-CoV-2 RNA in respiratory vesicles
Studies exploring extracellular vesicles (EVs) have uncovered an important piece of information: SARS-CoV-2 RNA was present in EVs in individuals who tested negative via standard RT-PCR methods.
-
NewsCOVID-19 vaccine candidates show robust boosting potential
Two COVID-19 vaccines have shown strong potential to be an improved approach for boosting immunity to SARS-CoV-2 variants according to interim results of a Phase 1 clinical trial.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsAdvanced MRI technology detects changes in the brain after COVID-19
Researchers have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people.
-
NewsScientists find new, better way to develop vaccines
Researchers have developed a new system to display epitopes in mammal cells for immunization studies and believe that this method can help scientists greatly in immunization efforts.
-
NewsT cells tackle new ‘Pirola’ SARS-CoV-2 variant
Scientists harness bioinformatics to predict how T cells may adapt to fighting the highly mutated Pirola variant.
-
NewsHIV drug could prevent coronaviruses, study finds
New research has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration.
-
NewsNew study highlights COVID-19’s adaptive strategy for infection
Researchers have discovered a novel mechanism whereby the SARS-CoV-2 virus, which causes COVID-19, can vary its mode of infection in human cells.
-
News Nano-sized cell particles are promising tool in treating infectious diseases
In a new study, extracellular vesicles were found to inhibit the viral infection of COVID-19 and potentially other infectious diseases.
-
NewsMink discovery challenges standard understanding of COVID-19 infection
Researchers studying zoonosis — the interspecies transmission of pathogens — in mink have found that TMPRSS2, an enzyme critical for viral fusion entry of SARS-CoV-2 in humans, is not functional in mink.
